{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:tivanisiran [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT00074737: Phase 2 Interventional Completed Acute Myelogenous Leukemia
(2004)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01065935: Phase 2 Interventional Completed Respiratory Syncytial Virus Infections
(2010)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT02781883: Phase 2 Interventional Recruiting Acute Myeloid Leukemia (AML)
(2016)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:avacincaptad pegol [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT02147197: Phase 3 Interventional Completed Leiomyoma
(2014)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01191372: Phase 1 Interventional Terminated Hemophilia
(2010)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03974113: Phase 3 Interventional Active, not recruiting Hemophilia
(2020)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT00694785: Phase 2 Interventional Withdrawn Von Willebrand Disease
(2008)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT01899729: Phase 2 Interventional Completed Plaque Psoriasis
(2013)
Source URL:
Class:
NUCLEIC ACID